129 related articles for article (PubMed ID: 35863671)
1. Tumor Control Probability After Radiosurgery of Brain Metastases With and Without Retreatment.
Sharma M; Milano MT; Cummings M; Naqa IE
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):537-544. PubMed ID: 35863671
[TBL] [Abstract][Full Text] [Related]
2. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
3. Ten-Fraction Stereotactic Radiosurgery With Different Gross Tumor Doses and Inhomogeneities for Brain Metastasis of >10 cc: Treatment Responses Suggesting Suitable Biological Effective Dose Formula for Single and 10 Fractions.
Ohtakara K; Nakabayashi K; Suzuki K
Cureus; 2023 Feb; 15(2):e34636. PubMed ID: 36895545
[TBL] [Abstract][Full Text] [Related]
4. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.
Soltys SG; Milano MT; Xue J; Tomé WA; Yorke E; Sheehan J; Ding GX; Kirkpatrick JP; Ma L; Sahgal A; Solberg T; Adler J; Grimm J; El Naqa I
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):100-111. PubMed ID: 33375955
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
[TBL] [Abstract][Full Text] [Related]
7. Volumetric-Modulated Arc-Based Re-radiosurgery With Simultaneous Reduced-Dose Whole-Brain Irradiation for Local Failures Following Prior Radiosurgery of Brain Oligometastases From Small Cell Lung Cancer.
Ohtakara K; Arakawa S; Nakao M; Muramatsu H; Suzuki K
Cureus; 2023 Aug; 15(8):e44492. PubMed ID: 37791190
[TBL] [Abstract][Full Text] [Related]
8. 5-Fraction Re-radiosurgery for Progression Following 8-Fraction Radiosurgery of Brain Metastases From Lung Adenocarcinoma: Importance of Gross Tumor Coverage With Biologically Effective Dose ≥80 Gy and Internal Dose Increase.
Ohtakara K; Tanahashi K; Kamomae T; Suzuki K
Cureus; 2023 Jul; 15(7):e42299. PubMed ID: 37609081
[TBL] [Abstract][Full Text] [Related]
9. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord.
Choi CY; Adler JR; Gibbs IC; Chang SD; Jackson PS; Minn AY; Lieberson RE; Soltys SG
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):499-506. PubMed ID: 20133079
[TBL] [Abstract][Full Text] [Related]
11. A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities.
Gui C; Grimm J; Kleinberg LR; Zaki P; Spoleti N; Mukherjee D; Bettegowda C; Lim M; Redmond KJ
Adv Radiat Oncol; 2020; 5(5):840-849. PubMed ID: 33083646
[TBL] [Abstract][Full Text] [Related]
12. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
[TBL] [Abstract][Full Text] [Related]
13. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
14. Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers.
Quashie EE; Li XA; Prior P; Awan M; Schultz C; Tai A
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37903437
[No Abstract] [Full Text] [Related]
15. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
16. Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy.
Shehata MK; Young B; Reid B; Patchell RA; St Clair W; Sims J; Sanders M; Meigooni A; Mohiuddin M; Regine WF
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):87-93. PubMed ID: 15093903
[TBL] [Abstract][Full Text] [Related]
17. Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study.
Zindler JD; Schiffelers J; Lambin P; Hoffmann AL
Strahlenther Onkol; 2018 Jun; 194(6):560-569. PubMed ID: 29349605
[TBL] [Abstract][Full Text] [Related]
18. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
[TBL] [Abstract][Full Text] [Related]
19. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
[TBL] [Abstract][Full Text] [Related]
20. Repeat Stereotactic Radiosurgery for Locally Recurrent Brain Metastases.
Koffer P; Chan J; Rava P; Gorovets D; Ebner D; Savir G; Kinsella T; Cielo D; Hepel JT
World Neurosurg; 2017 Aug; 104():589-593. PubMed ID: 28450235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
